Can Cancer-Related Proteins be Targeted for Therapy?
Yes, targeting cancer-related proteins is a central strategy in modern oncology. Therapies such as monoclonal antibodies and small molecule inhibitors have been developed to specifically target proteins like HER2 and EGFR. These targeted therapies aim to inhibit the function of these proteins, thereby slowing down or stopping cancer progression.
